AK

Aravind Kumar Tripathi

Active Director Director DIN 11346272
DIN 11346272 First appointment Oct 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Aravind Kumar Tripathi

Data last updated:

Aravind Kumar Tripathi is a Director at Redvaxin (I) Private Limited (since 2025). The company operates in Biotechnology.

DIN 11346272
Primary Designation Director
Industry Biotechnology
First Appointment 17 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Redvaxin (I) Private Limited U21001GJ2025PTC168835
Director17 Oct 20252025Active

Board colleagues of Aravind Kumar Tripathi

NameDINCompanyDesignation
Amit Kumar10383286Redvaxin (I) Private LimitedDirector
Aparna Rajput08790227Redvaxin (I) Private LimitedDirector

Directorship timeline

Open interactive timeline →
Redvaxin (I) Private Limited
Premium access

Shareholding and investment profile for Aravind Kumar Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aravind Kumar Tripathi

Aravind Kumar Tripathi currently holds 1 directorship: Redvaxin (I) Private Limited (Director, since 17 Oct 2025).

Aravind Kumar Tripathi was first appointed on 17 Oct 2025 as Director at Redvaxin (I) Private Limited.

The current boards of Aravind Kumar Tripathi's companies include Amit Kumar (Redvaxin (I) Private Limited), Aparna Rajput (Redvaxin (I) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available